Navigation Links
Studies Presented at Diabetes Technology Meeting Demonstrate the Accuracy of ARKRAY Blood Glucose Meters and Test Strips
Date:10/23/2015

MINNEAPOLIS, Oct. 23, 2015 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes care products, announced that two studies presented yesterday at the Diabetes Technology Meeting in Bethesda, Maryland  demonstrated the accuracy of ARKRAY's GLUCOCARD® Shine meter and the GLUCOCARD Vital™ meter in measuring blood glucose levels. The ability to accurately measure glucose levels in blood is essential for people afflicted with diabetes so they can effectively manage the disease, according to the American Diabetes Association (ADA).

"The results of these studies show ARKRAY products meet new ISO accuracy performance requirements for blood glucose meters," said ARKRAY USA President Jonathan Chapman. "These studies demonstrate our commitment to provide affordable, accurate blood glucose meters and test strips that help those afflicted with diabetes to live a more fulfilling and healthier life."

Diabetes, or diabetes mellitus, is a metabolic type of disease in which affected people have high blood glucose (blood sugar), either because insulin production is inadequate (Type 2), or because the islet cells in the pancreas no longer produce insulin (Type 1, sometimes referred to juvenile diabetes). People with untreated diabetes typically experience frequent urination, become increasingly thirsty and hungry. The ADA estimates that more than 30 million Americans suffer from either Type 1 or Type 2 diabetes and that 25.9% of American's 65 years of age or greater will have diabetes.

About ARKRAY USA, Inc.

ARKRAY USA, Inc. is a division of ARKRAY, a global leader in diabetes care with headquarters in Kyoto, Japan. For more than half a century, ARKRAY has pioneered products to ensure that people who have diabetes - and the health professionals who care for them - can better manage the condition.  ARKRAY currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the U.S. The Company has a long history of developing cutting edge technology such as the first portable glucose analyzer available in the United States; the first HbA1C analyzer; and the first hand-held blood glucose meter. For more information, visit www.arkrayusa.com.

 


'/>"/>
SOURCE ARKRAY USA, Inc.
Copyright©2015 PR Newswire.
All rights reserved


Related medicine technology :

1. Studies Show Respiratory Volume Monitoring May Offer Better Protection for Women in Labor and Obese Patients
2. Isis Pharmaceuticals Initiates SHINE Study to Provide ISIS-SMN Rx for Patients With SMA Who Have Completed the Phase 3 ENDEAR and CHERISH Studies
3. MEI Pharma Announces Data from Phase II Clinical Studies of Pracinostat Accepted for Oral Presentation at American Society of Hematology Annual Meeting
4. Xybion announces that Novo Nordisk selects Pristima to manage pharmacology research studies across all research sites
5. UbiVac Announces Collaboration with Johnson & Johnson Innovation to Develop and Test, in Preclinical Studies, a Vaccine to Intercept Oral Cancer
6. AbbVies ABT-494 Meets Primary Endpoint in Two Phase 2 Studies in Rheumatoid Arthritis
7. DelMar Pharmaceuticals Presents Clinical Protocol for Advancement of VAL-083 into Phase IV Studies as a Treatment for Non-Small Cell Lung Cancer
8. Medical Device Studies: Clinical Evidence Course - London, UK - November 10-11, 2015
9. NeuroPhages NPT088 Universally Targets Misfolded Proteins in Preclinical Studies Highlighted in Oral Session at the Alzheimers Association International Conference
10. Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness in Childhood Cancer
11. New Clinical Studies Prove that Asking Patients the Right Questions Can Improve Quality, Reduce Costs of Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2020)... ... , ... Bridge To A Cure Foundation announces the appointment of Henry Friedman, ... who serves on the Board of Directors at The Preston Robert Tisch Brain Tumor ... Internationally recognized, Dr. Friedman is a widely published author of more than 500 peer ...
(Date:8/26/2020)... ST. CHARLES, Mo. (PRWEB) , ... ... ... Bioanalytical Services, a member of Eurofins BioPharma Services, Laboratory Testing division, expands ... to the existing suite of Flow Cytometry platforms available. With industry-leading biomarker ...
(Date:8/26/2020)... ... August 26, 2020 , ... ... CHPCA, LNC has added CHC and CPCO to her name. , That’s thanks ... Healthcare Compliance (CHC) and the Certified Professional Compliance Officer (CPCO.) , The CHC ...
Breaking Medicine Technology:
(Date:9/3/2020)... ... September 03, 2020 , ... ... sponsoring the American Foundation for Suicide Prevention’s (AFSP) annual signature event, Out of ... across hundreds of U.S. cities to raise awareness of suicide prevention. To ensure ...
(Date:9/2/2020)... ... September 02, 2020 , ... RAM ... payers administering Medicare Advantage and Special Needs plans, is proud to support the ... Insurance Plans (AHIP). RAM is supporting the event as a sponsor and exhibitor ...
(Date:9/1/2020)... Fla. (PRWEB) , ... September 01, 2020 , ... ... Reconstructive Surgeon with specialty fellowship training in aesthetic surgery of the face, breast, ... MD – the only female-owned premier boutique plastic surgery and aesthetic practice in ...
(Date:8/31/2020)... ... ... Want to get moving, break up your routine, and make a difference right ... its fourth annual STEPtember campaign in the United States to raise funds and awareness ... at this moment — encouraging people to move in the ways that work for ...
(Date:8/31/2020)... ... ... Covid-19 “PTS” with Mediation & Hypnosis , At this very turbulent time in the ... anxiety, immense stress, and right now are needing serious relief from a constant state of ... are experiencing a great degree of emotional discomfort, be it fear or worrying about their ...
Breaking Medicine News(10 mins):